Clinical Trial

National Bacterial Meningitis Study in Children and Newborns

Recruiting
View on ClinicalTrials.gov →
Summary
Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-12-07; most recent amendment 2026-04-23.
Trial Details
NCT Number NCT04664569
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Pfizer
Conditions Meningitis, Children, Only, Pneumococcal Conjugate Vaccine, Meningococcal Vaccines, H. Influenzae Vaccine, Neonatal Infection, Antibiotic Treatment, Case Fatality Rate
Enrollment 10,000 participants
Start Date 2001-01-01
Primary Completion 2030-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-28